Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

FIND A TRIAL NEAR YOU

No location found for this Zip Code

-- or --

No location found for this Location

Pediatric ADHD Trial

A phase 2/3, classroom setting, randomized trial of NRCT-101SR in pediatric patients, age 13-17, with ADHD. 

ADHD, also called attention-deficit disorder, is a behavior disorder, usually first diagnosed in childhood, that is characterized by inattention, impulsivity, and, in some cases, hyperactivity. These symptoms usually occur together; however, one may occur without the other(s). 

The symptoms of hyperactivity, when present, are almost always apparent by the age of 7 and may be present in very young preschoolers. Inattention or attention-deficit may not be evident until a child faces the expectations of elementary school. 

Eligibility Criteria: 

  • Children 13-17 years old 
  • Diagnosed with ADHD and is experiencing symptoms 
  • Fluent in English
     

Study Duration: Approximately 11-17 weeks (about 4 months), with optional open-label extension up to 6 weeks (about 1 and a half months). 

Create a Profile

I accept digital forms of communication(Required)
Hidden
Hidden
This field is for validation purposes and should be left unchanged.

Get In Touch Mobile

I accept digital forms of communication(Required)
This field is for validation purposes and should be left unchanged.

Study Locations

Accel Research Sites | Maitland
2300 Maitland Center Parkway
Maitland, Florida 32751